John Tilton, Chief Commercial Officer at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 10,500 shares at $37.67 ($396K) on 2019-01-10, disclosed to the SEC on 2019-01-14.
Open-market sale of $396k BHVN by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BHVN | SELL | 2017-11-02 | $878K | — | Filing → |